Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 12:0_12:0_16:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Cardiovascular disease Nanjing Medical University Other
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Diabetes Nanjing Medical University Other
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Obesity Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Cardiovascular disease Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Diabetes Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Obesity Nanjing Medical University Other
ST003757 AN006168 Untargeted lipidomics of gemcitabine-resistant PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006160 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006160 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003664 AN006020 Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. T-cells Mouse Cancer University of Chicago LC-MS
ST003632 AN005965 Dysregulated Lipid Metabolism in African American Women Who Experienced Cardiometabolic Complications of Pregnancy Blood Human Preeclampsia Emory University LC-MS
ST003364 AN005511 Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease Aortic valve tissue Human Heart disease Technical University Dresden LC-MS
ST003341 AN005475 Untargeted Lipidomic Profiling of Canine Cancer Cell Lines Cultured cells Dog Cancer Kojin Therapeutics, Inc. LC-MS
ST003185 AN005232 A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - plasma lipidomics Blood Mouse Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003184 AN005229 A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - tumor lipidomics Tumor cells Mouse Cancer University of Colorado Anschutz Medical Campus LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002414 AN003935 Mass spectrometry dataset of LC-MS Lipidomics Analysis of Xenopus Laevis Optic Nerve Eye tissue Frog Eye disease University of Miami LC-MS
ST001849 AN002995 Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) Blood Human COVID-19 Washington University in St. Louis LC-MS
ST001111 AN001805 Breast Cancer Lipidomics Tissue Adipose tissue Human Cancer Baylor College of Medicine LC-MS
  logo